Mechanisms of the joint-protective effects of p38 MAPK inhibitors in rodent arthritis

Author： Mbalaviele Gabriel Monahan Joseph B

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.3, Iss.2, 2008-02, pp. : 163-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 867-874

Bentham Science Publishers

Access to resources Recommend Favorite

p38 MAPK inhibitors: a patent review (2012 – 2013)

By Bühler Stefanie Laufer Stefan A

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 535-554

Informa Healthcare

Access to resources Recommend Favorite

The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections

Current Drug Metabolism, Vol. 10, Iss. 1, 2009-01 ,pp. : 55-67

Bentham Science Publishers

Access to resources Recommend Favorite

5-Amino-2-carbonylthiophene derivatives for use as p38 MAPK inhibitors in the treatment of inflammatory diseases

By Boehm Jeffrey

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 10, 2005-10 ,pp. : 1471-1476

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of p38 kinase

By Hanson G.J.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 7, 1997-07 ,pp. : 729-733

Informa Healthcare

Access to resources Recommend Favorite